A detailed history of Klingman & Associates, LLC transactions in Danaher Corp stock. As of the latest transaction made, Klingman & Associates, LLC holds 2,017 shares of DHR stock, worth $460,985. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,017
Previous 1,806 11.68%
Holding current value
$460,985
Previous $451,000 24.17%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$239.25 - $280.76 $50,481 - $59,240
211 Added 11.68%
2,017 $560,000
Q2 2024

Jul 30, 2024

BUY
$235.51 - $267.98 $4,710 - $5,359
20 Added 1.12%
1,806 $451,000
Q1 2024

May 01, 2024

BUY
$224.58 - $256.19 $11,902 - $13,578
53 Added 3.06%
1,786 $445,000
Q4 2023

Jan 29, 2024

SELL
$185.1 - $233.13 $12,401 - $15,619
-67 Reduced 3.72%
1,733 $400,000
Q3 2023

Oct 30, 2023

BUY
$233.08 - $265.59 $83,442 - $95,081
358 Added 24.83%
1,800 $446,000
Q2 2023

Jul 31, 2023

SELL
$224.99 - $256.14 $7,424 - $8,452
-33 Reduced 2.24%
1,442 $346,000
Q1 2023

May 03, 2023

SELL
$239.75 - $277.0 $20,378 - $23,545
-85 Reduced 5.45%
1,475 $371,000
Q4 2022

Feb 03, 2023

BUY
$241.42 - $282.29 $31,143 - $36,415
129 Added 9.01%
1,560 $414,000
Q3 2022

Oct 28, 2022

BUY
$247.06 - $1507.4 $7,411 - $45,222
30 Added 2.14%
1,431 $370,000
Q2 2022

Jul 27, 2022

BUY
$237.11 - $299.66 $7,350 - $9,289
31 Added 2.26%
1,401 $355,000
Q1 2022

May 06, 2022

BUY
$257.27 - $315.76 $3,344 - $4,104
13 Added 0.96%
1,370 $402,000
Q4 2021

Jan 31, 2022

BUY
$292.08 - $329.01 $99,015 - $111,534
339 Added 33.3%
1,357 $446,000
Q3 2021

Nov 01, 2021

BUY
$272.21 - $332.43 $277,109 - $338,413
1,018 New
1,018 $310,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $166B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Klingman & Associates, LLC Portfolio

Follow Klingman & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klingman & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Klingman & Associates, LLC with notifications on news.